Two Seas Capital LP Esperion Therapeutics, Inc. Transaction History
Two Seas Capital LP
- $297 Million
- Q3 2024
A detailed history of Two Seas Capital LP transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Two Seas Capital LP holds 6,584,278 shares of ESPR stock, worth $14.7 Million. This represents 3.65% of its overall portfolio holdings.
Number of Shares
6,584,278
Previous 5,735,660
14.8%
Holding current value
$14.7 Million
Previous $12.7 Million
14.68%
% of portfolio
3.65%
Previous 5.09%
Shares
6 transactions
Others Institutions Holding ESPR
# of Institutions
206Shares Held
128MCall Options Held
1.67MPut Options Held
930K-
Wasatch Advisors Inc Salt Lake City, UT23.3MShares$52.3 Million0.19% of portfolio
-
Black Rock Inc. New York, NY14MShares$31.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13MShares$29.2 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V89.94MShares$22.3 Million0.28% of portfolio
-
Geode Capital Management, LLC Boston, MA4.33MShares$9.7 Million0.0% of portfolio
About Esperion Therapeutics, Inc.
- Ticker ESPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 66,551,600
- Market Cap $149M
- Description
- Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...